Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database

Thromb Res. 2016 Oct:146:43-45. doi: 10.1016/j.thromres.2016.08.014. Epub 2016 Aug 24.

¹ St Esprit Hospital, Emergency Department, Agen, France.
² AP-HP, European Hospital Georges Pompidou, Pharmacovigilance Department, Paris, France.
³ Université de Brest, EA3878 Brest, France; University of Ottawa, Department of Medicine, Ottawa, Canada.
⁴ Paris Descartes University, Sorbonne Paris Cité, Paris, France; Inserm UMR-S1140, Paris, France; AP-HP, European Hospital Georges Pompidou, Hematology Department, Paris, France. Electronic address: david.smadja@aphp.fr.

No abstract available

Publication types